Global Cardiology Summit October 22-23, 2018 Osaka, Japan

About Conference

We coordially welcome you to the CME and CPD accredited event Global Cardiology Summit which will be held in Osaka, Japan during October 22-23, 2018 organized by Conference Series llc LTD. Cardiology Summit will be a platform to bring together world-class cardiologists, cardiac surgeons and cardiac professors to discuss strategies for remediation of the disease for cardiac disorders. Cardiology Summits are designed to provide a diversified education and present latest technologies in order to keep medical professionals updated with current trends in the field of prevention, diagnosis and treatment of cardiac diseases. The Global Cardiology Summits mainly focused on spreading the awareness about challenges in this fields and how to prevent and manage the advanced techniques.

 Conference series llc LTD 1000+ CME Global events every year across the globe with support from 1000+ more scientific societies and Publishes 500 Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Cardiology Summit 2018 welcomes the Cardiologists, Surgoens, Physicians, and Academicians from cardiology as well as  healthcare sectors to be a part of it. The event will definitely add value in the professional field of participants.

Why to Attend?

Cardiology Summit 2018 is a best suitable platform where you can meet cardiologists and cardiac experts from all over the world. Scientists from industries, Research scholars, Academicians and Society members will also join the summit to gain the knowledge and present their work in this particular field. The topics of the Cardiology Summit will reflect the recent advances, current trends, future trends and new approaches in Cardiology. The other scientific sessions will include Cardiovascular Diseases, Cardiac Pharmacology and other diseases in association with Cardiology, Veterinary Cardiology, Heart Surgery and Ethical issues in cardiology and many more. 

Target Audience:

Cardiology Summit 2018 welcomes:

• Cardiology Summit 2018 welcomes:
• Cardiologists
• Cardiac Surgeons
• Healthcare Professionals
• Cardiothoracic Surgeons
• Cardiology Physicians
• Nurse Practitioners
• Cardiovascular Researchers
• Cardiovascular Doctors
• Cardiovascular Scientists
• Electrophysiologists
• Cardiac Sonographers
• Cardiac Perfusionists
• Medical Students and Ph.D. Fellows
• Business Entrepreneurs
• Manufacturing Medical Devices Companies

Conference Series llc LTD welcome you to be a part of  CME and CPD certified International Annual Conference “Global Cardiology Summit”. This conference will be held during October 22-23, 2018 at Osaka, Japan. Cardiology Summit-2018 is a best suitable international platform for all the cardiac specialists and research scholars related to cardiology field. This summit allows to share and to know about the current research and advances in the relevant field of cardiology.

Track 1: Cardiology

Cardiology is a branch of medicine which deals with the study of disorders of the heart as well as parts of the circulatory system. This field includes medical diagnosis and treatment of congenital heart defects. Cardiologists are medical doctors who specialize in heart and blood vessel disease. They help in preventing the disease as well as diagnose and treat those who already have them. Cardiology is divided into several fields such as pediatric cardiology, adult cardiology, interventional procedures, electrophysiology and echocardiography etc. 

Related conferences: Cardiology Summit | Cardiology Conferences | Cardiology Meetings

22nd World Cardiology Conference, December 11-12, 2017 Rome, Italy; 2nd World Heart Congress, May 14-16, 2018 Tokyo, Japan; 3rd World Heart Congress, April 19-20, 2018 Amsterdam, Netherlands; 23rd European Heart Disease and Heart Failure Congress, February 19-21, 2018 Paris, France; 20th European Cardiology Conference, October 16-18, 2017 Budapest, Hungary; 23rd World Cardiology Conference, 19-20 March, 2018 Dubai, UAE; 24th Annual Cardiologists Conference, June 11-13, 2018 Barcelona, Spain; 25th Annual Cardiologists Conference, November 19-20, 2018 Singapore; 2nd International Conference on Hypertension and Healthcare, September 11-13, 2017 Amsterdam, Netherlands; 21st International Conference on Clinical & Experimental Cardiology, November 06-07, 2017 Las Vegas, USA; 59th Annual World Congress 2017 September 7- 9, 2017 Vienna, Austria; Update in Clinical Cardiology, October 11-13, 2017 Boston, United States; International Academy of Cardiology, July 27-29, 2018 Boston, Mass; 4th International 4 Corners of Cardiology 2018, February 9-10, 2018 Melbourne, Australia; 23rd Cardiovascular Summit TCTAP 2018, April 28-May 1, 2018, Coex, Seoul, Korea.

Related Societies: Asian Pacific Society of Cardiology (APSC); Spanish Society of Cardiology (SSC); Japanese Circulation Society (JCJ); Philippine Heart Association (PHA); Asian Society of Cardiothoracic Anesthesia (ASCA); Japanese Circulation Society (JCS); Turkish Society of Cardiology (TSC); American Society of Cardiology (ASC); European Society of Cardiology (ESC); German Society of Pediatric Cardiology (GSPC); Society of Geriatric Cardiology (SGC); International Society of Cardiovascular Pharmacology (ISCP); German Society of Cardiac, Thoracic and Vascular Surgery (GSCTVS); International Society for Minimally Invasive Cardiac Surgery (ISMICS); Heart Failure Society of America (HFSA); Vietnam Heart Association(VHA); Emirates Cardiac Society (ECS).

Track 2: Heart and Cardivascular Diseases

Cardiovascular diseases (CVD) are the leading cause of death globally. These are the class of diseases that involve the heart or blood vessels. It is estimated that 90% of CVD is preventable. Existing cardiovascular disease or a previous cardiovascular event such as a heart attack or stroke is the strongest predictor of a future cardiovascular event. The common symptom of CVD is pain or discomfort in the centre of the chest, in the arms and left shoulder, elbows, jaw or back. Feeling sick or vomiting, difficulty in breathing, feeling light-headed or fainting, breaking into a cold sweat and becoming pale may also be shown as additional symptom. At least three quarters of the world's deaths from CVDs occur in low- and middle-income countries. This is because they do not have the benefit of integrated primary health care programmes for early detection and treatment.

Related conferences: Cardiology Summit | Heart disease conferences | Cardiovascular conferences

23rd European Heart Disease and Heart Failure Congress, February 19-21, 2018 Paris, France; 20th European Cardiology Conference, October 16-18, 2017 Budapest, Hungary; 3rd World Heart Congress, April 19-20, 2018 Amsterdam, Netherlands; 23rd World Cardiology Conference, 19-20 March, 2018 Dubai, UAE; 24th Annual Cardiologists Conference, June 11-13, 2018 Barcelona, Spain; 2nd International Conference on Hypertension & Healthcare, September 11-13, 2017 Amsterdam, Netherland; 25th Annual Cardiologists Conference, November 19-20, 2018 Singapore; September 11-13, 2017 Amsterdam, Netherlands; 21st International Conference on Clinical & Experimental Cardiology, November; Annual Conference on Clinical & Medical Case Reports in Cardiology, July 05-06, 2018 Frankfurt, Germany; 3rd International Conference on Cardiovascular Medicine and Cardiac Surgery, July 05-06, 2018 Frankfurt, Germany; 22nd World Congress on Heart Disease, July 14-16, 2017 Vancouver, BC, Canada; Cardiovascular Disease Management: A Case-Based Approach, 5th Annual Symposium 2017, October 5-6, 2017, Phoenix, Az, United States; 12th International Congress on Innovations in Coronary Artery Disease (ICCAD), October 15-17, 2017 Venice, Italy; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, Calif; 27th International Symposium on Adult Congenital Heart Disease, September 14-16, 2017 Cincinnati, Ohio, United States; 44th Annual Williamsburg Conference on Heart Disease, December 03-05, 2017, Williamsburg, VA, United States.

Related Societies: Asian Pacific Society of Cardiology (APSC); Spanish Society of Cardiology (SSC); Japanese Circulation Society (JCJ); Philippine Heart Association (PHA); Asian Society of Cardiothoracic Anesthesia (ASCA); Japanese Circulation Society (JCS); Turkish Society of Cardiology (TSC); American Society of Cardiology (ASC); European Society of Cardiology (ESC); German Society of Pediatric Cardiology (GSPC); Society of Geriatric Cardiology (SGC); International Society of Cardiovascular Pharmacology (ISCP); German Society of Cardiac, Thoracic and Vascular Surgery (GSCTVS); International Society for Minimally Invasive Cardiac Surgery (ISMICS); Heart Failure Society of America (HFSA); Vietnam Heart Association(VHA); Emirates Cardiac Society (ECS).

Track 3: Lipid and Metabolic Syndromes

Metabolic syndrome is the major cause that contribute to cardiovascular morbidity and mortality. It is a cluster of metabolic disorders, such as dyslipidemia, abdominal obesity, hypertension and impaired fasting glucose which will increase the risk for cardiovascular disease. The dietary lipids are also recognized to contribute in the development and the prevention of cardiovascular risk clustering. This review explores the relevant mechanisms involved in the influence of dietary fatty acids on metabolic syndrome components.

The development of metabolic syndrome mainly due to Genetics and the environmental factors. Approximately 20%-30% of the population in industrialized countries has metabolic syndrome and the people with Metabolic syndrome will have three times higher risk of developing cardiovascular disease. Additionally, statin drugs play a key role in the treatment of people with coronary heart disease, mostly because they lower LDL cholesterol.

The treatment choices include changing lifestyle and weight reduction which usually requires a specifically tailored, multifaceted program that includes diet and exercise. Medications also may be useful.

Related conferences: Cardiology Summit | Cardiology Events | Cardiology Meetings

3rd World Heart Congress, April 19-20, 2018 Amsterdam, Netherlands; 23rd European Heart Disease and Heart Failure Congress, February 19-21, 2018 Paris, France; 20th European Cardiology Conference, October 16-18, 2017 Budapest, Hungary; 23rd World Cardiology Conference, 19-20 March, 2018 Dubai, UAE; 24th Annual Cardiologists Conference, June 11-13, 2018 Barcelona, Spain; 2nd International Conference on Hypertension & Healthcare, September 11-13, 2017 Amsterdam, Netherlands; 25th Annual Cardiologists Conference, November 19-20, 2018 Singapore; 3rd International Conference on Cardiovascular Medicine and Cardiac Surgery, July 05-06, 2018 Frankfurt, Germany; Annual Conference on Clinical & Medical Case Reports in Cardiology, July 05-06, 2018 Frankfurt, Germany; 21st International Conference on Clinical & Experimental Cardiology, November 06-07, 2017 Las Vegas, USA; 2nd Excellence in Cardiac Care Congress, November 10-11, 2017 Dubai, UAE; 59th Annual World Congress 2017 September 7- 9, 2017 Vienna, Austria; Update in Clinical Cardiology, October 11-13, 2017 Boston, United States; International Academy of Cardiology, July 27-29, 2018 Boston, Mass; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, Calif; International Academy of Cardiology, July 27-29, 2018 Boston, Mass.

Related Societies: Asian Pacific Society of Cardiology (APSC); Spanish Society of Cardiology (SSC); Japanese Circulation Society (JCJ); Philippine Heart Association (PHA); Asian Society of Cardiothoracic Anesthesia (ASCA); Japanese Circulation Society (JCS); Turkish Society of Cardiology (TSC); American Society of Cardiology (ASC); European Society of Cardiology (ESC); German Society of Pediatric Cardiology (GSPC); Society of Geriatric Cardiology (SGC); International Society of Cardiovascular Pharmacology (ISCP); German Society of Cardiac, Thoracic and Vascular Surgery (GSCTVS); International Society for Minimally Invasive Cardiac Surgery (ISMICS); Heart Failure Society of America (HFSA); Vietnam Heart Association(VHA); Emirates Cardiac Society (ECS).

Track 4: Interventional Cardiology and Heart Surgery

Interventional cardiology involves the correction of harmed or debilated vessels, narrowed arteries or other affected parts of the heart structure. It is a non surgical procedure which uses a small flexible tube called catheter for treatment. The heart can be subjected to many procedures by catheterization. It commonly involves the insertion of catheter into the heart chamber/coronary arteries/valves of cardiac system and cannulating the heart under X-ray visualization or most commonly fluoroscopy. The adaptation of this type of treatment avoids the scars and pain and long post-operative recovery. The procedures involved in interventional cardiology result in substantial patient radiation doses due to prolonged fluoroscopy time and radiographic exposure.

Cardiac surgery or heart surgery is surgery on the heart or great vessels. It is performed in order to correct the problems associated with the heart.  Cardiac surgeon is a specialist in cardiac surgery. Newer methods of heart surgery (such as off-pump and minimally invasive) may reduce risks and speed up recovery time when compared to traditional open heart surgery. A heart specialist performs cardiac surgery to repair or replace heart valves, repair abnormal or damaged structures in the heart, implant medical devices that help control the heartbeat or support heart function and blood flow or to replace a damaged heart with a healthy heart from a donor.  

Related conferences: Interventional Cardiology Conferences | Cardiology Summit | Cardiology Meetings

22nd World Cardiology Conference, December 11-12, 2017 Rome, Italy; 3rd World Heart Congress, April 19-20, 2018 Amsterdam, Netherlands;  23rd European Heart Disease and Heart Failure Congress, February 19-21, 2018 Paris, France; 20th European Cardiology Conference, October 16-18, 2017 Budapest, Hungary; 25th Annual Cardiologists Conference, November 19-20, 2018 Singapore; 2nd International Conference on Hypertension & Healthcare, September 11-13, 2017 Amsterdam, Netherlands; 21st International Conference on Clinical & Experimental Cardiology, November 06-07, 2017 Las Vegas, USA. 3rd International Conference on Cardiovascular Medicine and Cardiac Surgery, July 05-06, 2018 Frankfurt, Germany; International Conference on Cardiovascular Imaging, November 19-21, 2018 Melbourne, Australia; 2nd International Conference on Non-invasive Cardiac Imaging, Nuclear Cardiology & Echocardiography, September 11-13, 2017 Amsterdam, Netherlands; 28th Annual Cardiovascular Interventions 2017, November 7-10, 2017 La Jolla, CA;13th Asian Interventional Cardiovascular Therapeutics (AICT 2017), November 24-25, 2017 Melbourne, Australia; Outpatient Endovascular and Interventional Society (OEIS) 5th Annual Meeting, April 20-22, 2018 Scottsdale, AZ; 23rd Cardiovascular Summit TCTAP 2018, April 28-May 1, 2018, Coex, Seoul, Korea; New Cardiovascular Horizons 19th Annual Conference, May 30- June 1, 2018 New Orleans, LA.

Related Societies: Asian Pacific Society of Cardiology (APSC); Spanish Society of Cardiology (SSC); Japanese Circulation Society (JCJ); Philippine Heart Association (PHA); Asian Society of Cardiothoracic Anesthesia (ASCA); Japanese Circulation Society (JCS); Turkish Society of Cardiology (TSC); American Society of Cardiology (ASC); European Society of Cardiology (ESC); German Society of Pediatric Cardiology (GSPC); Society of Geriatric Cardiology (SGC); International Society of Cardiovascular Pharmacology (ISCP); German Society of Cardiac, Thoracic and Vascular Surgery (GSCTVS); International Society for Minimally Invasive Cardiac Surgery (ISMICS); Heart Failure Society of America (HFSA); Vietnam Heart Association(VHA); Emirates Cardiac Society (ECS).

Track 5: Cardiovascular Pharmacology

Cardiovascular Pharmacology deals with the study of the effects of drugs upon the heart or circulatory system. It mainly contributes to the safety profile of potential new drugs and provides pharmacological data that can be used for optimization of further compounds and the ultimate selection of compounds suitable for clinical development. The cardiac drugs affect the function of the heart in three main ways. They can affect the force of contraction of the heart muscle (inotropic effects), they can affect the frequency of the heart beat or heart rate (chronotropic effects) or they can affect the regularity of the heart beat (rhythmic effects). Drugs can also affect blood vessels by altering the state of compression of the smooth muscle in the vessel wall, altering its diameter and accordingly directing the volume of blood stream. Such medications are classified as vasoconstrictors or vasodilators depending on the smooth muscle lining contraction and relaxation respectively.

Related Conferences: Cardiac Pharmacology Conferences | Cardiovascular Pharmacology Events | Cardiology Conferences

22nd World Cardiology Conference, December 11-12, 2017 Rome, Italy; 3rd World Heart Congress, April 19-20, 2018 Amsterdam, Netherlands;  20th European Cardiology Conference, October 16-18, 2017 Budapest, Hungary; 25th Annual Cardiologists Conference, November 19-20, 2018 Singapore; 3rd International Conference on  Cardiovascular Medicine and Cardiac Surgery, July 05-06, 2018 Frankfurt, Germany; 21st International Conference on Clinical & Experimental Cardiology, November 06-07, 2017 Las Vegas, USA; 2nd International Conference on Hypertension & Healthcare, September 11-13, 2017 Amsterdam, Netherlands; 3rd International Conference on Cardiovascular Medicine and Cardiac Surgery, July 05-06, 2018 Frankfurt, Germany; 2nd International Conference on Non-invasive Cardiac Imaging, Nuclear Cardiology & Echocardiography, September 11-13, 2017 Amsterdam, Netherlands; International Conference on Cardiovascular Imaging, November 19-21, 2018 Melbourne, Australia; 6th Global Experts Meeting on Cardiology and Cardiovascular Pharmacology, October 20-21, 2017 Osaka, Japan; 19th International Conference on Cardiovascular Pharmacology and Pharmacodynamics (ICCPP 2017), December 11-12, 2017; The American Society for Pharmacology and Experimental Therapeutics (ASPET), April 21-25, 2018 San Diego, CA; 6^th Global Experts Meeting on Cardiology and Cardiovascular Pharmacology, October 20-21, 2017 Osaka, Japan; The Official Meeting of the ESC Working Group on Cardiovascular Pharmacotherapy, May 13-14, 2018, Tel Aviv, Israel.

Related Societies: Asian Pacific Society of Cardiology (APSC); Spanish Society of Cardiology (SSC); Japanese Circulation Society (JCJ); Philippine Heart Association (PHA); Asian Society of Cardiothoracic Anesthesia (ASCA); Japanese Circulation Society (JCS); Turkish Society of Cardiology (TSC); American Society of Cardiology (ASC); European Society of Cardiology (ESC); German Society of Pediatric Cardiology (GSPC); Society of Geriatric Cardiology (SGC); International Society of Cardiovascular Pharmacology (ISCP); German Society of Cardiac, Thoracic and Vascular Surgery (GSCTVS); International Society for Minimally Invasive Cardiac Surgery (ISMICS); Heart Failure Society of America (HFSA); Vietnam Heart Association(VHA); Emirates Cardiac Society (ECS).

Track 6: Cardio-Oncology

Cardio-oncology is the discipline that concentrates on the intersection of heart diseases and cancer. This field is growing at a faster rate because the survivors after cancer therapies are more prone to develop cardiovascular disease. The increase in cancer disease in the world has led to the emergence of numerous chemotherapeutic agents which are under preclinical or clinical studies. These agents are potent to cause damage to the heart (carddiotoxicity). Cardiotoxic effects of chemotherapy might be decreased by the concurrent use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers or beta-blockers. The use of diagnostic imaging, noninvasive stress testing, serum biomarkers, ambulatory blood pressure monitoring and ambulatory cardiac telemetry can help to identify cardiotoxicities and lead to the development of preventative strategies. 

Related Conferences: Cardio-Oncology Conferences | Clinical Cardiology Conferences | Cardiology Summit

22nd World Cardiology Conference, December 11-12, 2017 Rome, Italy; 3rd World Heart Congress, April 19-20, 2018 Amsterdam, Netherlands; 21st International Conference on Clinical & Experimental Cardiology, November 06-07, 2017 Las Vegas, USA; 23rd European Heart Disease and Heart Failure Congress, February 19-21, 2018 Paris, France; 20th European Cardiology Conference, October 16-18, 2017 Budapest, Hungary; 3rd International Conference on Cardiovascular Medicine and Cardiac Surgery, July 05-06, 2018 Frankfurt, Germany; 25th Annual Cardiologists Conference, November 19-20, 2018 Singapore; 23rd World Cardiology Conference, 19-20 March, 2018 Dubai, UAE; Annual Conference on Clinical & Medical Case Reports in Cardiology, July 05-06, 2018 Frankfurt, Germany; 2nd International Conference on Hypertension & Healthcare, September 11-13, 2017 Amsterdam, Netherlands; 3rd Meeting of Cardio-Oncology / Cardiac Inaccuracy, May 11-12, 2018 Athens, Greece; Global Cardio-Oncology Summit 2017, September 20-21, 2017 London, England; 3rd Cardiac MRI Conference: Focus on Ischaemic Heart Disease, October 26 October 2017 Liverpool, UK; International Academy of Cardiology, July 27-29, 2018 Boston, Mass; 4th International 4 Corners of Cardiology 2018, February 9-10, 2018 Melbourne, Australia.

Related Societies: Asian Pacific Society of Cardiology (APSC); Spanish Society of Cardiology (SSC); Japanese Circulation Society (JCJ); Philippine Heart Association (PHA); Asian Society of Cardiothoracic Anesthesia (ASCA); Japanese Circulation Society (JCS); Turkish Society of Cardiology (TSC); American Society of Cardiology (ASC); European Society of Cardiology (ESC); German Society of Pediatric Cardiology (GSPC); Society of Geriatric Cardiology (SGC); International Society of Cardiovascular Pharmacology (ISCP); German Society of Cardiac, Thoracic and Vascular Surgery (GSCTVS); International Society for Minimally Invasive Cardiac Surgery (ISMICS); Heart Failure Society of America (HFSA); Vietnam Heart Association(VHA); Emirates Cardiac Society (ECS).

Track 7: Occupational Heart Disease

Occupational cardiovascular disease or occupational heart disease is the disease of the heart or blood vessels that are caused by working conditions. Certain toxins including carbon disulfide, nitroglycerin and carbon monoxide in the work area are known to cause heart diseases. Additionally extreme heat and cold, exposure to tobacco smoke, depression and occupational stress is the reason for heart disease. Other occupational hazards potentially related to cardiovascular disease include noise exposure at work, shift work and physical activity at work.

Related Conferences: Occupational Cardiology Conferences | Cardiology Summit | Cardiology Meetings

3rd World Heart Congress, April 19-20, 2018 Amsterdam, Netherlands; 23rd European Heart Disease and Heart Failure Congress, February 19-21, 2018 Paris, France; 20th European Cardiology Conference, October 16-18, 2017 Budapest, Hungary; 23rd World Cardiology Conference, 19-20 March, 2018 Dubai, UAE; 24th Annual Cardiologists Conference, June 11-13, 2018 Barcelona, Spain; 2nd International Conference on Hypertension & Healthcare, September 11-13, 2017 Amsterdam, Netherlands; 25th Annual Cardiologists Conference, November 19-20, 2018 Singapore; September 11-13, 2017 Amsterdam, Netherlands; 3rd International Conference on Cardiovascular Medicine and Cardiac Surgery, July 05-06, 2018 Frankfurt, Germany; Annual Conference on Clinical & Medical Case Reports in Cardiology, July 05-06, 2018 Frankfurt, Germany; 21st International Conference on Clinical & Experimental Cardiology, November 06-07, 2017 Las Vegas, USA; 2nd Excellence in Cardiac Care Congress, November 10-11, 2017 Dubai, UAE; 59th Annual World Congress 2017 September 7- 9, 2017 Vienna, Austria; Update in Clinical Cardiology, October 11-13, 2017 Boston, United States; International Academy of Cardiology, July 27-29, 2018 Boston, Mass; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, Calif; International Academy of Cardiology, July 27-29, 2018 Boston, Mass.

Related Societies: Asian Pacific Society of Cardiology (APSC); Spanish Society of Cardiology (SSC); Japanese Circulation Society (JCJ); Philippine Heart Association (PHA); Asian Society of Cardiothoracic Anesthesia (ASCA); Japanese Circulation Society (JCS); Turkish Society of Cardiology (TSC); American Society of Cardiology (ASC); European Society of Cardiology (ESC); German Society of Pediatric Cardiology (GSPC); Society of Geriatric Cardiology (SGC); International Society of Cardiovascular Pharmacology (ISCP); German Society of Cardiac, Thoracic and Vascular Surgery (GSCTVS); International Society for Minimally Invasive Cardiac Surgery (ISMICS); Heart Failure Society of America (HFSA); Vietnam Heart Association(VHA); Emirates Cardiac Society (ECS).

Track 8: Pediatric Cardiology

Pediatric cardiology is a branch of medicine deals with heart related problems in new born, infants, children and adolescents. A pediatric cardiologist is a pediatrician who has received extensive training in diagnosing and treating children's cardiac problems. Currently, evaluating and treating the disease condition may begin with the fetus since heart problems can now be detected before birth. Hence this division is actively involved in therapeutic conclusion and treatment of preventing both congenital and acquired heart disease in children. Finally, the division is committed to educating the next generation of physicians and offers advanced training in pediatric cardiology. 

Related Conferences: Pediatric Cardiology Conferences | Pediatric Cardiology Meetings | Cardiology Summit

22nd World Cardiology Conference, December 11-12, 2017 Rome, Italy; 2nd World Heart Congress, May 14-16, 2018 Tokyo, Japan; 3rd World Heart Congress, April 19-20, 2018 Amsterdam, Netherlands; 23rd European Heart Disease and Heart Failure Congress, February 19-21, 2018 Paris, France; 20th European Cardiology Conference, October 16-18, 2017 Budapest, Hungary; 23rd World Cardiology Conference, 19-20 March, 2018 Dubai, UAE; 24th Annual Cardiologists Conference, June 11-13, 2018 Barcelona, Spain; 25th Annual Cardiologists Conference, November 19-20, 2018 Singapore; 2nd International Conference on Hypertension & Healthcare, September 11-13, 2017 Amsterdam, Netherlands; 21st International Conference on Clinical & Experimental Cardiology, November 06-07, 2017 Las Vegas, USA; 2nd Annual Advances in Pediatric and Congenital Heart Summit 2017, November 9-11, 2017 Cleveland, United States; 6th Annual Practical Topics in Pediatric Emergency Medicine, February 2-4, 2018 Florida, United States; 42nd Annual Florida Suncoast Pediatric Conference, June 21-24, 2018 Florida, United States; World Society for Pediatric and Congenital Heart Surgery, July 23-26, 2018 Florida, United States; 8th World Congress of Pediatric Cardiology and Cardiac Surgery, September 19-24, 2021 Washington, D.C. 

Related Societies: Asian Pacific Society of Cardiology (APSC); Spanish Society of Cardiology (SSC); Japanese Circulation Society (JCJ); Philippine Heart Association (PHA); Asian Society of Cardiothoracic Anesthesia (ASCA); Japanese Circulation Society (JCS); Turkish Society of Cardiology (TSC); American Society of Cardiology (ASC); European Society of Cardiology (ESC); German Society of Pediatric Cardiology (GSPC); Society of Geriatric Cardiology (SGC); International Society of Cardiovascular Pharmacology (ISCP); German Society of Cardiac, Thoracic and Vascular Surgery (GSCTVS); International Society for Minimally Invasive Cardiac Surgery (ISMICS); Heart Failure Society of America (HFSA); Vietnam Heart Association(VHA); Emirates Cardiac Society (ECS).

Track 9: Cardiogeriatrics

Cardiogeriatrics or geriatric cardiology deals with the cardiovascular   diagnosis and management of heart disease in the elderly population. As the population ages, an increasing number of elderly people will develop cardiovascular diseases and will suffer their consequences. Cardiac disorders such as coronary heart disease and others are common and are a major cause of mortality in elderly people. Vascular disorders such as atherosclerosis and peripheral arterial disease cause significant morbidity in aged people. Cardiovascular disease at elderly age is superimposed on the cardiovascular changes of aging, most of which underlie many common disorders of aging and limit the physiologic compensatory mechanisms for disease.

CVD is also usually more hazardous in older patients. It often erupts with multiple simultaneous CVD processes (e.g., acute coronary syndrome, heart failure, and atrial fibrillation) and in combination with non-cardiac pathologies (e.g., pneumonia, renal insufficiency, anemia, chronic lung disease, diabetes, stroke). Such multisystem disease combinations are more liable to overwhelm the diminished CV reserve capacity of aging, thus leading to adverse outcomes.

Related Conferences: Geriatric Cardiology Conferences | Cardiology Summit | Clinical Cardiology Conferences

22nd World Cardiology Conference, December 11-12, 2017 Rome, Italy; 2nd World Heart Congress, May 14-16, 2018 Tokyo, Japan; 3rd World Heart Congress, April 19-20, 2018 Amsterdam, Netherlands; 23rd European Heart Disease and Heart Failure Congress, February 19-21, 2018 Paris, France; 20th European Cardiology Conference, October 16-18, 2017 Budapest, Hungary; 23rd World Cardiology Conference, 19-20 March, 2018 Dubai, UAE; 24th Annual Cardiologists Conference, June 11-13, 2018 Barcelona, Spain; 25th Annual Cardiologists Conference, November 19-20, 2018 Singapore; 2nd International Conference on Hypertension & Healthcare, September 11-13, 2017 Amsterdam, Netherlands; 21st International Conference on Clinical & Experimental Cardiology, November 06-07, 2017 Las Vegas, USA; MENA Geriatrics Summit (MGS 2017), November 2-3, 2017 Dubai, United Arab Emirates; 2nd Excellence in Cardiac Care Congress, November 10-11, 2017 Dubai, UAE; 59th Annual World Congress 2017 September 7- 9, 2017 Vienna, Austria; Update in Clinical Cardiology, October 11-13, 2017 Boston, United States; International Academy of Cardiology, July 27-29, 2018 Boston, Mass; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, Calif. 

Related Societies: Asian Pacific Society of Cardiology (APSC); Spanish Society of Cardiology (SSC); Japanese Circulation Society (JCJ); Philippine Heart Association (PHA); Asian Society of Cardiothoracic Anesthesia (ASCA); Japanese Circulation Society (JCS); Turkish Society of Cardiology (TSC); American Society of Cardiology (ASC); European Society of Cardiology (ESC); German Society of Pediatric Cardiology (GSPC); Society of Geriatric Cardiology (SGC); International Society of Cardiovascular Pharmacology (ISCP); German Society of Cardiac, Thoracic and Vascular Surgery (GSCTVS); International Society for Minimally Invasive Cardiac Surgery (ISMICS); Heart Failure Society of America (HFSA); Vietnam Heart Association(VHA); Emirates Cardiac Society (ECS).

Track 10: Sports and Exercise Cardiology

Sports and Exercise Cardiology is concerned with the cardiovascular care of athletes and exercising individuals of all ages, advancing the knowledge through fostering education, clinical expertise and research. Sports medicine, also known as sport and exercise medicine (SEM) is a branch of medicine that deals with physical fitness and the treatment and prevention of injuries related to sports and exercise. In recent years, athletic participation has increased in all major demographic groups, while simultaneously, children and adults with established heart disease desire participation in sports and exercise. Despite conferring favorable long-term effects on well-being and survival, exercise can be associated with risk of adverse events in the short term. Cardiologists face various challenges in evaluating the athletes due to complex individual cardiovascular demand and adaptations imposed by exercise.

Related Conferences: Sports Cardiology Meetings | Exercise Cardiology Conference | Heart Conference

2nd World Heart Congress, May 14-16, 2018 Tokyo, Japan; 23rd European Heart Disease and Heart Failure Congress, February 19-21, 2018 Paris, France; 20th European Cardiology Conference, October 16-18, 2017 Budapest, Hungary; 23rd World Cardiology Conference, 19-20 March, 2018 Dubai, UAE; 24th Annual Cardiologists Conference, June 11-13, 2018 Barcelona, Spain; 2nd International Conference on Hypertension & Healthcare, September 11-13, 2017 Amsterdam, Netherlands; 25th Annual Cardiologists Conference, November 19-20, 2018 Singapore; September 11-13, 2017 Amsterdam, Netherlands; 3rd International Conference on Cardiovascular Medicine and Cardiac Surgery, July 05-06, 2018 Frankfurt, Germany; Annual Conference on Clinical & Medical Case Reports in Cardiology, July 05-06, 2018 Frankfurt, Germany; 21st International Conference on Clinical & Experimental Cardiology, November 06-07, 2017 Las Vegas, USA; 7th Annual Advances in Cardiovascular Imaging and Interventions, October 5-7, 2017 Troy, MI, United States; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, Calif; International Academy of Cardiology, July 27-29, 2018 Boston, Mass; The Role of Cardiac MRI in Clinical Cardiology, April 28, 2018 Chicago, IL, United States; Comprehensive EKG Seminar - Diagnostic skills for myocardial ischemia, infarction, arrhythmia interpretation and current treatment strategies, October 31, 2018 Key West, FL, United States.

Related Societies: Asian Pacific Society of Cardiology (APSC); Spanish Society of Cardiology (SSC); Japanese Circulation Society (JCJ); Philippine Heart Association (PHA); Asian Society of Cardiothoracic Anesthesia (ASCA); Japanese Circulation Society (JCS); Turkish Society of Cardiology (TSC); American Society of Cardiology (ASC); European Society of Cardiology (ESC); German Society of Pediatric Cardiology (GSPC); Society of Geriatric Cardiology (SGC); International Society of Cardiovascular Pharmacology (ISCP); German Society of Cardiac, Thoracic and Vascular Surgery (GSCTVS); International Society for Minimally Invasive Cardiac Surgery (ISMICS); Heart Failure Society of America (HFSA); Vietnam Heart Association(VHA); Emirates Cardiac Society (ECS).

Track 11: Cardiac Diagnosis, Imaging And Medical Tests

Cardiac diagnostic tests are the methods and techniques of detecting heart conditions related with healthy and pathologic heart function. Doctor will diagnose coronary heart disease (CHD) based on patient’s medical and family histories, risk factors, a physical exam and the results from tests and procedures. No single test can diagnose CHD. The patient may have to undergo one or more tests.  Common diagnostic tests include Angiogram, Blood tests, Blood pressure monitoring, Chest X-ray, Echocardiogram, MRI and ECG, Electrophysiology studies, Stress test or Tilt test. New tests are constantly being developed to further the understanding of disease, injury and congenital (present at birth) or acquired abnormalities of the heart. 

Related Conferences: Cardiovascular Conference | Cardiac Surgery Conferences | Cardiology Summit

3rd International Conference on Cardiovascular Medicine and Cardiac Surgery, July 05-06, 2018 Frankfurt, Germany; 21st International Conference on Clinical & Experimental Cardiology, November 06-07, 2017 Las Vegas, USA; 23rd European Heart Disease and Heart Failure Congress, February 19-21, 2018 Paris, France; International Conference on Cardiovascular Imaging, November 19-21, 2018 Melbourne, Australia; 23rd World Cardiology Conference, 19-20 March, 2018 Dubai, UAE; 2nd International Conference on Non-invasive Cardiac Imaging, Nuclear Cardiology & Echocardiography, September 11-13, 2017 Amsterdam, Netherlands; 2nd International Conference on Hypertension & Healthcare, September 11-13, 2017 Amsterdam, Netherlands; 24th Annual Cardiologists Conference, June 11-13, 2018 Barcelona, Spain; 20th European Cardiology Conference, October 16-18, 2017 Budapest, Hungary; Annual Conference on Clinical & Medical Case Reports in Cardiology, July 05-06, 2018 Frankfurt, Germany; 7th Annual International Hawaii Symposium on Diagnostic and Therapeutic Modalities in Heart Failure, November 30-December 02, 2017, Kamuela, HI, United States; Device Therapies for Heart Failure, December 15-16, 2017 Berlin, Germany; 13th Asian Interventional Cardiovascular Therapeutics (AICT 2017), November 24-25, 2017 Melbourne, Australia; 23rd Cardiovascular Summit TCTAP 2018, April 28-May 1, 2018, Coex, Seoul, Korea; New Cardiovascular Horizons 19th Annual Conference, May 30- June 1, 2018New Orleans, LA.

Related Societies: Asian Pacific Society of Cardiology (APSC); Spanish Society of Cardiology (SSC); Japanese Circulation Society (JCJ); Philippine Heart Association (PHA); Asian Society of Cardiothoracic Anesthesia (ASCA); Japanese Circulation Society (JCS); Turkish Society of Cardiology (TSC); American Society of Cardiology (ASC); European Society of Cardiology (ESC); German Society of Pediatric Cardiology (GSPC); Society of Geriatric Cardiology (SGC); International Society of Cardiovascular Pharmacology (ISCP); German Society of Cardiac, Thoracic and Vascular Surgery (GSCTVS); International Society for Minimally Invasive Cardiac Surgery (ISMICS); Heart Failure Society of America (HFSA); Vietnam Heart Association(VHA); Emirates Cardiac Society (ECS).

Track 12: Cardiac Regeneration

Cardiac regeneration aims to correct irreversibly damaged heart tissue with cutting-edge science, including cell-free and stem cell therapy. Reparative tools have been engineered to restore the damaged heart tissue and function using the body's natural capability to regenerate. The cardiac specialists with the support of are finding regenerative solutions that restore, renew and recycle patients' own reparative capacity.

The damaged skeletal muscle has a profound capacity to regenerate, heart muscle, at least in mammals, has poor regenerative potential. This deficiency is attributable to the lack of resident cardiac stem cells, combined with obstacles that limit adult cardiomyocytes from entering the cell cycle and completing division. The idea of regeneration came into existence due to the innate ability to regenerate in animals. The innovation of stem cell and reprogramming technologies and a clearer understanding of the cardiomyocyte genetic program and key extrinsic signals helped to undertake further study on heart regeneration. Strategies to augment heart regeneration have potential to counteract the high morbidity and mortality of cardiovascular disease. 

Related Conferences: Cardiac Regeneration Conference | Clinical Cardiology Conferences| Cardiovascular Conference

21st International Conference on Clinical & Experimental Cardiology, November 06-07, 2017 Las Vegas, USA; 3rd International Conference on Cardiovascular Medicine and Cardiac Surgery, July 05-06, 2018 Frankfurt, Germany; 2nd International Conference on Hypertension & Healthcare, September 11-13, 2017 Amsterdam, Netherlands; International Conference on Cardiovascular Imaging, November 19-21, 2018 Melbourne, Australia; 23rd European Heart Disease and Heart Failure Congress, February 19-21, 2018 Paris, France; 23rd World Cardiology Conference, 19-20 March, 2018 Dubai, UAE; 24th Annual Cardiologists Conference, June 11-13, 2018 Barcelona, Spain; 2nd International Conference on Non-invasive Cardiac Imaging, Nuclear Cardiology & Echocardiography, September 11-13, 2017 Amsterdam, Netherlands; 20th European Cardiology Conference, October 16-18, 2017 Budapest, Hungary Annual Conference on Clinical & Medical Case Reports in Cardiology, July 05-06, 2018 Frankfurt, Germany; 7th NHLBI Cardiovascular Regenerative Medicine Symposium 2017, September 27-28, 2017 Bethesda, MD; 20th International Conference on Tissue Engineering and Regenerative Medicine Applications (ICTERMA 2018), May 10-11, 2018, Amsterdam, Netherlands; The 6th Annual Utah Cardiac Recovery Symposium, January 11-12, 2018 Salt Lake City, Utah; 2nd Excellence in Cardiac Care Congress, November 10-11, 2017 Dubai, UAE; 59th Annual World Congress 2017 September 7- 9, 2017 Vienna, Austria.

Related Societies: Asian Pacific Society of Cardiology (APSC); Spanish Society of Cardiology (SSC); Japanese Circulation Society (JCJ); Philippine Heart Association (PHA); Asian Society of Cardiothoracic Anesthesia (ASCA); Japanese Circulation Society (JCS); Turkish Society of Cardiology (TSC); American Society of Cardiology (ASC); European Society of Cardiology (ESC); German Society of Pediatric Cardiology (GSPC); Society of Geriatric Cardiology (SGC); International Society of Cardiovascular Pharmacology (ISCP); German Society of Cardiac, Thoracic and Vascular Surgery (GSCTVS); International Society for Minimally Invasive Cardiac Surgery (ISMICS); Heart Failure Society of America (HFSA); Vietnam Heart Association(VHA); Emirates Cardiac Society (ECS).

Track 13: Cardiac Nursing 

Cardiac nursing is a specialty nursing that works with patients who experience the ill effects of different states of the cardiovascular system. A cardiac care nurse or cardiac nurse is an expertise who cares specifically for patients with heart issues. While the obligations and duties of a nurse with this title may change from setting to setting, they will treat patients who have experienced or endure different sorts of heart problems under the direction of cardiologists. They perform various tasks such as performing stress tests, care for a patient after an operation, complete health assessments or closely monitor the patient’s heart rate.  

Related Conferences: Cardiac Nursing Conference | Cardiology Summit | Cardiology Meetings

Cardiovascular diseases are the number one cause of death globally. CVDs are responsible for over 3 million diseases annually. Some of the major CVDs include coronary heart diseases, stroke, hypertensive heart diseases, inflammatory heart diseases, rheumatoid heart diseases and others.  Coronary heart diseases are the leading cause of death followed by strokes. The prevalence and incidence rate of heart diseases are on a rise; especially in major emerging countries such as India, China, and Japan. The market of cardiology surgery, devices and drugs are also on a rise.

The Cardiology market is growing rapidly and is expected to reach $97 billion by 2018 globally. Worldwide Interventional Cardiac Devices business sector was worth US$20.6 billion in 2016, developing at a CAGR of 9.2% during 2012-2018 market analysis. North American region represents most astounding rate roughly 35.8% (2015) of worldwide offer while Europe is the 2nd leader with almost 28.8% (2018) of the business sector. Asia-Pacific is the quickest developing region with a CAGR of 11.6% driving a business sector estimation of US$4.7 billion.

The interventional cardiology & peripheral vascular devices market was valued at USD 21.83 Billion in 2016 and expected to grow at a CAGR of 7.1% to reach USD 31.47 Billion in 2021. Factors such as rising geriatric population, increase demand for minimally invasive angioplasty treatment and technology advancement are contributing to the growth of this market.

The global cardiology market includes interventional and cardiovascular devices. Global interventional cardiology surgery, devices and drugs market is expected to grow at a CAGR of 7.3% for the forecasted period of 2017-2021. North America is the leading market with highest market share. The market is expected to grow at a CAGR of 6.9 percent. North American marker is followed by Europe, Asia-Pacific and rest of the world. Asia Pacific market is expected to have highest CAGR of 9.5% for the forecasted period of 2017-2021.  

Conference Highlights

Cardiology

Heart and Cardiovascular Diseases

Lipid and Metabolic Syndromes

Interventional Cardiology and Heart Surgery

Cardiovascular Pharmacology

Cardio-Oncology                 

Occupational Heart Disease

Pediatric Cardiology

Cardiogeriatrics

Sports and Exercise Cardiology

Cardiac Diagnosis, Imaging and Medical Tests

Cardiac Regeneration

Cardiac Nursing 

Hypertension and Healthcare

Clinical Trials in Cardiology 

Veterinary Cardiology

Advances In Cardiology

Personalized Medicine-The Future

Cardiology Ethics and Case Reports